Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 8
Submit an article Journal homepage
348
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant

Amer M. BeitinjanehDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA;Stem Cell Transplantation Program, Department of Internal Medicine, University of Virginia, Charlottesville, VA, USACorrespondence[email protected]
,
Rima SalibaDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Qaiser BashirDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Nina ShahDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Simrit ParmarDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Chitara HosingDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Uday PopatDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Paolo AnderliniDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Yvonne DinhDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Sofia QureshiDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Gabriela RondonDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Richard E. ChamplinDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Sergio A. GiraltDepartment of Stem Cell Transplantation, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
&
Muzaffar H. QazilbashDepartment of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
 show all
Pages 1525-1529 | Received 19 Sep 2011, Accepted 08 Jan 2011, Published online: 01 Mar 2012

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Moreno Festuccia, Massimo Martino, Federica Ferrando, Giuseppe Messina, Tiziana Moscato, Roberta Fedele, Mario Boccadoro, Luisa Giaccone & Benedetto Bruno. (2015) Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs. Expert Opinion on Biological Therapy 15:6, pages 857-872.
Read now

Articles from other publishers (21)

Jakub Krejcik, Mike Bogetofte Barnkob, Charlotte Guldborg Nyvold, Thomas Stauffer Larsen, Torben Barington & Niels Abildgaard. (2021) Harnessing the Immune System to Fight Multiple Myeloma. Cancers 13:18, pages 4546.
Crossref
Panayotis Kaloyannidis & John Apostolidis. (2021) Allogeneic Stem Cell Transplantation in Patients with High-Risk Multiple Myeloma: Utopia or Continuous Challenge in Aiming for Cure?. Current Treatment Options in Oncology 22:8.
Crossref
Xiang Zhou, Hermann Einsele & Sophia Danhof. (2020) Bispecific Antibodies: A New Era of Treatment for Multiple Myeloma. Journal of Clinical Medicine 9:7, pages 2166.
Crossref
Liana Nikolaenko, Saurabh Chhabra, Noa Biran, Arnab Chowdhury, Parameswaran N. Hari, Amrita Krishnan & Joshua Richter. (2020) Graft-Versus-Host Disease in Multiple Myeloma Patients Treated With Daratumumab After Allogeneic Transplantation. Clinical Lymphoma Myeloma and Leukemia 20:6, pages 407-414.
Crossref
Hossein Maymani, Paul Lin, Rima M. Saliba, Uday Popat, Qaiser Bashir, Nina Shah, Krina Patel, Simrit Parmar, Partow Kebriaei, Chitra Hosing, Stefan Ciurea, Borje Andersson, Elizabeth Shpall, Richard Champlin, Samer A. Srour & Muzaffar H. Qazilbash. (2019) Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens. Biology of Blood and Marrow Transplantation 25:5, pages 1039-1044.
Crossref
Michael Tveden Gundesen, Thomas Lund, Hanne E. H. Moeller & Niels Abildgaard. (2019) Plasma Cell Leukemia: Definition, Presentation, and Treatment. Current Oncology Reports 21:1.
Crossref
Maximilian Gröger, Nico Gagelmann, Christine Wolschke, Ute-Marie von Pein, Evgeny Klyuchnikov, Max Christopeit, Axel Zander, Francis Ayuk & Nicolaus Kröger. (2018) Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 24:7, pages 1399-1405.
Crossref
D. Nicole Worsham, Jo‐Anna Reems, Zbigniew M. Szczepiorkowski, David H. McKenna, Thomas Leemhuis, Aby J. Mathew & Jose A. Cancelas. (2017) Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T‐cell subpopulations. Transfusion 57:6, pages 1555-1565.
Crossref
Toshihiro Miyamoto, Takahiro Fukuda, Marie Nakashima, Tomoko Henzan, Shinsuke Kusakabe, Naoki Kobayashi, Junichi Sugita, Takeshi Mori, Mineo Kurokawa & Shin-ichiro Mori. (2017) Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program. Biology of Blood and Marrow Transplantation 23:6, pages 938-944.
Crossref
Leo Rasche, Niels Weinhold, Gareth J. Morgan, Frits van Rhee & Faith E. Davies. (2017) Immunologic approaches for the treatment of multiple myeloma. Cancer Treatment Reviews 55, pages 190-199.
Crossref
Qaiser Bashir & Muzaffar H. Qazilbash. (2017) Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work. Current Hematologic Malignancy Reports 12:2, pages 126-135.
Crossref
Leo Rasche, Christoph Röllig, Gernot Stuhler, Sophia Danhof, Stephan Mielke, Goetz Ulrich Grigoleit, Lea Dissen, Lea Schemmel, Jan Moritz Middeke, Viktoria Rücker, Martin Schreder, Johannes Schetelig, Martin Bornhäuser, Hermann Einsele, Christian Thiede & Stefan Knop. (2016) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Focus on Longitudinal Assessment of Donor Chimerism, Extramedullary Disease, and High-Risk Cytogenetic Features. Biology of Blood and Marrow Transplantation 22:11, pages 1988-1996.
Crossref
Luca Castagna, Barbara Sarina, Stefania Bramanti, Paolo Perseghin, Jacopo Mariotti & Lucio Morabito. (2016) Donor lymphocyte infusion after allogeneic stem cell transplantation. Transfusion and Apheresis Science 54:3, pages 345-355.
Crossref
Richard Champlin. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation 836 844 .
Michele L. Donato, David S. Siegel, David H. Vesole, Phyllis McKiernan, Themba Nyirenda, Andrew L. Pecora, Melissa Baker, Stuart L. Goldberg, Anthony Mato, Andre Goy & Scott D. Rowley. (2014) The Graft-Versus-Myeloma Effect: Chronic Graft-Versus-Host Disease but Not Acute Graft-Versus-Host Disease Prolongs Survival in Patients with Multiple Myeloma Receiving Allogeneic Transplantation. Biology of Blood and Marrow Transplantation 20:8, pages 1211-1216.
Crossref
Simrit Parmar & David S. Ritchie. (2014) Allogeneic transplantation as anticancer immunotherapy. Current Opinion in Immunology 27, pages 38-45.
Crossref
Mauricette Michallet, Mohamad Sobh, Jean El-Cheikh, Stéphane Morisset, Anne Sirvent, Oumedaly Reman, Jérôme Cornillon, Reza Tabrizi, Noel Milpied, Jean-Luc Harousseau, Hélène Labussière, Franck-Emmanuel Nicolini, Michel Attal, Philippe Moreau, Mohamad Mohty, Didier Blaise & Hérvé Avet-Loiseau. (2013) Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patients. Experimental Hematology 41:12, pages 1008-1015.
Crossref
Sergio Giralt & Guenther Koehne. (2013) Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: What Place, If Any?. Current Hematologic Malignancy Reports 8:4, pages 284-290.
Crossref
. (2013) Current World Literature. Current Opinion in Organ Transplantation 18:2, pages 241-250.
Crossref
. (2013) Current World Literature. Current Opinion in Oncology 25:2, pages 205-212.
Crossref
Hans-Jochem Kolb, Kerry Atkinson & Reinhold Munker. 2013. The BMT Data Book. The BMT Data Book 209 234 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.